Aromatase Deficiency and Estrogen Resistance: From Molecular Genetics to Clinic

ABSTRACT

Our knowledge of the physiologic roles of estrogen in women and men has been advanced by recent descriptions of mutations disrupting estrogen biosynthesis and action. Aromatase deficiency results from autosomal recessive inheritance of mutations in the CYP19 gene. It gives rise to ambiguous genitalia in 46,XX individuals. At puberty, affected girls have hypergonadotropic hypogonadism, fail to develop secondary sexual characteristics, and exhibit progressive virilization. The affected 46,XY individuals have normal male sexual differentiation and pubertal maturation. These men are extremely tall and have eunuchoid proportions with continued linear growth into adulthood, lack of epiphyseal closure, and osteoporosis due to estrogen deficiency. Although estrogen was shown to be essential for normal sperm production and function in mice, its role in fertility is not clear in men. Thus far, one estrogen-resistant human, a man with a mutant estrogen receptor-α gene, has been described. His clinical presentation was similar to that of aromatase-deficient men.

KEYWORD

deficiency - estrogen resistance - mutation

REFERENCES

• 1 Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency.  J Clin Endocrinol Metab . 1991;  72 560-566
• 2 Harada N, Ogawa H, Shozu M. Biochemical and molecular genetic analyses on placental aromatase (P450arom) deficiency.  J Biol Chem . 1992;  267 4781-4785
• 3 Portrat-Doyen S, Forest M G, Nicolino M, Morel Y, Chatelain P C. Female pseudohermaphroditism (FHP) resulting from aromatase (P450arom) deficiency associated with a novel mutation (R457) in the CYP19 gene.  Horm Res . 1996;  14-20 (14-20)
• 4 Ludwig M, Beck A, Wickert L. Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene.  J Pediatr Endocrinol Metab . 1998;  11 657-664
• 5 Deladoey K, Fluck C, Bex M, Yoshimura N, Harada N, Mullis P E. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy.  J Clin Endocrinol Metab . 1999;  84 4050-4054
• 6 Mullis P E, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.  J Clin Endocrinol Metab . 1997;  82 1739-1745
• 7 Conte F A, Grumbach M M, Ito Y, Fisher C R, Simpson E R. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).  J Clin Endocrinol Metab . 1994;  78 1287-1292
• 8 Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.  J Clin Endocrinol Metab . 1995;  80 3689-3698
• 9 Carani C, Qin K, Simoni M. Effect of testosterone and estradiol in a man with aromatase deficiency.  N Engl J Med . 1997;  337 91-95
• 10 Smith E P, Boyd J, Frank G R. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.  N Engl J Med . 1994;  331 1056-1061
• 11 Yalcinkaya T M, Siiteri P K, Vigne J. A mechanism for virilization of female spotted hyenas in utero.  Science . 1993;  260 1929-1931
• 12 Cagnacci A, Soldani R, Carriero P L, Paoletti A M, Fioretti P, Melis G B. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women.  J Clin Endocrinol Metab . 1992;  74 1396-1400
• 13 Casey M L, MacDonald P C, Simpson E R. Endocrinological changes of pregnancy. In: Foster DW, Wilson JD, eds. Williams Textbook of Endocrinology 8th ed. Philadelphia: WB Saunders 1992: 977-992
• 14 Verkauf B S, Reiter E D, Hernandez L, Burns S A. Virilization of mother and fetus associated with luteoma of pregnancy: a case report with endocrinologic studies.  Am J Obstet Gynecol . 1977;  129 274-280
• 15 Grumbach M M, Ducharme J R. The effects of androgens on fetal sexual development: androgen-induced female pseu-dohermaphroditism.  Fertil Steril . 1960;  11 157-180
• 16 Simpson E R, Mahendroo M S, Means G D. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.  Endocr Rev . 1994;  15 342-355
• 17 Corbin C J, Graham-Lorence S, McPhaul M, Mason J I, Mendelson C R, Simpson E R. Isolation of a full length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in non-steroidogenic cells.  Proc Natl Acad Sci U S A . 1988;  85 8948-8952
• 18 MacDonald P C, Madden J D, Brenner P F, Wilson J D, Siiteri P K. Origin of estrogen in normal men and in women with testicular feminization.  J Clin Endocrinol Metab . 1979;  49 905-916
• 19 Grodin J M, Siiteri P K, MacDonald P C. Source of estrogen production in postmenopausal women.  J Clin Endocrinol Metab . 1973;  36 207-214
• 20 Mahendroo M S, Means G D, Mendelson C R, Simpson E R. Tissue-specific expression of human P450arom: the promoter responsible for expression in adipose is different from that utilized in placenta.  J Biol Chem . 1991;  266 11276-11281
• 21 Mahendroo M S, Mendelson C R, Simpson E R. Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue.  J Biol Chem . 1993;  268 19463-19470
• 22 Siiteri P K, MacDonald P C. Placental estrogen biosynthesis during human pregnancy.  J Clin Endocrinol Metab . 1966;  26 751-761
• 23 Fisher C R, Graves K H, Parlow A F, Simpson E R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene.  Proc Natl Acad Sci U S A . 1998;  95 6965-6970
• 24 Lubahn D B, Moyer J S, Golding T S, Couse J F, Korach K S, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.  Proc Natl Acad Sci U S A . 1993;  90 11162-11166
• 25 Hess R A, Bunick D, Lee K H. A role of oestrogens in the male reproductive system.  Nature . 1997;  390 509-512
• 26 Robertson K M, O'Donnell L, Jones M E. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene.  Proc Natl Acad Sci U S A . 1999;  96 7986-7991
• 27 Finkelstein J S, O'Dea L S, Whitcomb R W, Crowley W F. Sex steroid control of gonadotropin secretion in the human male: II. Effects of estradiol administration in normal and GnRH deficient men.  J Clin Endocrinol Metab . 1991;  74 621-628
• 28 Bagatell C J, Dahl K D, Bremner W J. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.  J Androl . 1994;  15 15-21
• 29 Carani C, Rochira V, Faustini-Fustini M, Balestrieri A, Granata A R. Role of oestrogen in male sexual behavior: insights from the natural model of aromatase deficiency.  Clin Endocrinol (Oxf) . 1999;  51 517-524
• 30 Horowitz M C. Cytokines and estrogen in bone: anti-osteoporotic effects.  Science . 1993;  260 626-627
• 31 Jilka R L, Hangoc G, Girasole G. Increased osteoclast development after estrogen loss: mediation by interleukin-6.  Science . 1992;  257 88-91
• 32 Bilezikian J P, Morishima A, Bell J, Grumbach M M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.  N Engl J Med . 1998;  339 599-603
• 33 Bagatell C J, Knopp R H, Rivier J E, Bremner W J. Physiological levels of estradiol stimulate plasma high density lipoprotein₂ cholesterol levels in normal men.  J Clin Endocrinol Metab . 1994;  78 855-861
• 34 Rochira V, Faustini-Fustini M, Balestrieri A, Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.  J Clin Endocrinol Metab . 2000;  85 1841-1845